|
Name |
alpha-Gurjunene
|
Molecular Formula | C15H24 | |
IUPAC Name* |
(1aR,4R,4aR,7bS)-1,1,4,7-tetramethyl-1a,2,3,4,4a,5,6,7b-octahydrocyclopropa[e]azulene
|
|
SMILES |
C[C@@H]1CC[C@@H]2[C@@H](C2(C)C)C3=C(CC[C@H]13)C
|
|
InChI |
InChI=1S/C15H24/c1-9-6-8-12-14(15(12,3)4)13-10(2)5-7-11(9)13/h9,11-12,14H,5-8H2,1-4H3/t9-,11-,12-,14-/m1/s1
|
|
InChIKey |
SPCXZDDGSGTVAW-XIDUGBJDSA-N
|
|
Synonyms |
alpha-Gurjunene; (-)-alpha-Gurjunene; 489-40-7; (1aR,4R,4aR,7bS)-1,1,4,7-tetramethyl-1a,2,3,4,4a,5,6,7b-octahydro-1H-cyclopropa[e]azulene; alpha-Grujunene; Gurjunene-alpha; DTXSID0052126; CHEBI:61699; ZINC59200506; C19734; Q27131296; (1aR,4R,4aR,7bS)-1,1,4,7-tetramethyl-1a,2,3,4,4a,5,6,7b-octahydrocyclopropa[e]azulene
|
|
CAS | 489-40-7 | |
PubChem CID | 15560276 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 204.35 | ALogp: | 4.1 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 15 | QED Weighted: | 0.491 |
Caco-2 Permeability: | -4.585 | MDCK Permeability: | 0.00001880 |
Pgp-inhibitor: | 0.124 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.511 |
30% Bioavailability (F30%): | 0.486 |
Blood-Brain-Barrier Penetration (BBB): | 0.132 | Plasma Protein Binding (PPB): | 97.57% |
Volume Distribution (VD): | 5.067 | Fu: | 1.91% |
CYP1A2-inhibitor: | 0.723 | CYP1A2-substrate: | 0.592 |
CYP2C19-inhibitor: | 0.471 | CYP2C19-substrate: | 0.894 |
CYP2C9-inhibitor: | 0.548 | CYP2C9-substrate: | 0.389 |
CYP2D6-inhibitor: | 0.033 | CYP2D6-substrate: | 0.144 |
CYP3A4-inhibitor: | 0.478 | CYP3A4-substrate: | 0.421 |
Clearance (CL): | 9.203 | Half-life (T1/2): | 0.089 |
hERG Blockers: | 0.011 | Human Hepatotoxicity (H-HT): | 0.207 |
Drug-inuced Liver Injury (DILI): | 0.593 | AMES Toxicity: | 0.003 |
Rat Oral Acute Toxicity: | 0.317 | Maximum Recommended Daily Dose: | 0.125 |
Skin Sensitization: | 0.107 | Carcinogencity: | 0.036 |
Eye Corrosion: | 0.939 | Eye Irritation: | 0.917 |
Respiratory Toxicity: | 0.712 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003084 | 0.439 | D0S3WH | 0.293 | ||||
ENC002222 | 0.400 | D0N6FH | 0.276 | ||||
ENC002374 | 0.390 | D00YWP | 0.273 | ||||
ENC001408 | 0.377 | D0Y5ZA | 0.272 | ||||
ENC003074 | 0.377 | D04SFH | 0.267 | ||||
ENC001321 | 0.367 | D06XMU | 0.266 | ||||
ENC000808 | 0.367 | D07BSQ | 0.265 | ||||
ENC003090 | 0.367 | D0F1UL | 0.265 | ||||
ENC003089 | 0.359 | D0V2JK | 0.264 | ||||
ENC001192 | 0.349 | D08QMX | 0.256 |